We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$346M
AUM Growth
+$65.8M
Cap. Flow
-$8.87M
Cap. Flow %
-2.56%
Top 10 Hldgs %
48.65%
Holding
94
New
18
Increased
35
Reduced
23
Closed
15

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$9.02M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.78M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$4.51M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.21M
5
LOW icon
Lowe's Companies
LOW
+$3.74M

Top Sells

Rank Stock Value
1
JPM.WS
JPMorgan Chase
JPM.WS
+$17.5M
2
GILD icon
Gilead Sciences
GILD
+$8.83M
3
F icon
Ford
F
+$5.26M
4
BAC.WS.A
Bank Of America Corporation Ws A
BAC.WS.A
+$3.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.83M

Sector Composition

Rank Sector Weight
1 Healthcare 32.13%
2 Financials 12.03%
3 Communication Services 10.65%
4 Energy 9.04%
5 Technology 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$123B
$28.1M 8.14%
270,747
-23,121
-8% -$2.22M
MA icon
2
Mastercard
MA
$478B
$24.6M 7.1%
202,224
-21,215
-9% -$2.52M
AAPL icon
3
Apple
AAPL
$4.83T
$19.1M 5.51%
529,176
+50,432
+11% +$1.86M
CELG
4
DELISTED
Celgene Corp
CELG
$17.5M 5.06%
134,607
-7,215
-5% -$884K
META icon
5
Meta Platforms (Facebook)
META
$1.62T
$16.8M 4.87%
111,530
+1,355
+1% +$201K
BAC.WS.A
6
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$14.8M 4.27%
1,226,880
-299,400
-20% -$3.32M
JPM.WS
7
DELISTED
JPMorgan Chase
JPM.WS
$13.6M 3.93%
270,282
-387,445
-59% -$17.5M
IDXX icon
8
Idexx Laboratories
IDXX
$44.6B
$13.2M 3.81%
81,561
-1,130
-1% -$184K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.37T
$11M 3.18%
236,560
+90,060
+61% +$4.21M
ABMD
10
DELISTED
Abiomed Inc
ABMD
$9.62M 2.78%
+67,139
New +$9.02M
JPM icon
11
JPMorgan Chase
JPM
$907B
$8.87M 2.56%
97,001
-32,744
-25% -$2.83M
ILMN icon
12
Illumina
ILMN
$28.3B
$7.84M 2.27%
46,464
+13,449
+41% +$2.33M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$70.4B
$7.61M 2.2%
15,485
+13,200
+578% +$5.78M
PCRX icon
14
Pacira BioSciences
PCRX
$1.02B
$7.55M 2.18%
158,203
-6,419
-4% -$298K
SLB icon
15
SLB Ltd
SLB
$70.4B
$6.71M 1.94%
101,157
+5,092
+5% +$365K
FANG icon
16
Diamondback Energy
FANG
$54.8B
$6.45M 1.86%
72,607
+1,392
+2% +$135K
BMY icon
17
Bristol-Myers Squibb
BMY
$125B
$6.27M 1.81%
112,458
-11,909
-10% -$648K
VFC icon
18
VF Corp
VFC
$6.61B
$5.31M 1.54%
97,888
+7,287
+8% +$376K
CVX icon
19
Chevron
CVX
$375B
$5.21M 1.51%
49,425
+1,532
+3% +$162K
PM icon
20
Philip Morris
PM
$299B
$5.19M 1.5%
44,214
+1,631
+4% +$189K
LMT icon
21
Lockheed Martin
LMT
$118B
$4.94M 1.43%
17,685
-2,776
-14% -$763K
MMM icon
22
3M
MMM
$84B
$4.81M 1.39%
27,492
+1,078
+4% +$180K
ABBV icon
23
AbbVie
ABBV
$451B
$4.55M 1.32%
62,766
+3,654
+6% +$246K
CLB icon
24
Core Laboratories
CLB
$517M
$4.42M 1.28%
43,637
+980
+2% +$106K
EGRX
25
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4.36M 1.26%
+55,202
New +$4.51M
1
2 3 4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM

Biondo Investment Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Biondo Investment Advisors held 94 positions worth $346M, up 24% from $280M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Biondo Investment Advisors's Q2 2017 filing shows 18 new, 35 increased, 23 reduced and 15 closed positions. Its largest new stake was Abiomed Inc: 67,139 shares worth $9.62M. The largest sale was JPMorgan Chase, an estimated $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Financials and Communication Services.

  • Biondo Investment Advisors's largest Q2 2017 buy was Abiomed Inc: 67,139 shares worth $9.62M.
  • Biondo Investment Advisors added most to Regeneron Pharmaceuticals in Q2 2017, an estimated $5.78M increase.
  • Biondo Investment Advisors's biggest Q2 2017 reduction was JPMorgan Chase, cutting an estimated $17.5M.
  • Biondo Investment Advisors fully exited Gilead Sciences in Q2 2017, selling an estimated $8.83M.
  • Biondo Investment Advisors's ten largest holdings make up 49% of its $346M portfolio in Q2 2017.
  • Biondo Investment Advisors opened 18 new positions and closed 15 in Q2 2017.
  • Biondo Investment Advisors's portfolio value rose 24% quarter-over-quarter to $346M.

Based on Biondo Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.